Literature DB >> 23040116

Increased exhaled nitric oxide levels after exercise in patients with chronic systolic heart failure with pulmonary venous hypertension.

Andres Schuster1, Akanksha Thakur, Zeneng Wang, Allen G Borowski, James D Thomas, W H Wilson Tang.   

Abstract

BACKGROUND: Fractional exhaled nitric oxide (eNO) is recognized as a marker of pulmonary endothelial function. Oxidative stress is associated with systemic endothelial nitric oxide production, but its correlation with eNO in heart failure (HF) patients has not been described. Previous studies have reported increased eNO levels after exercise in symptomatic HF patients but decreased levels with pulmonary arterial hypertension. Our objective was to prospectively examine the potential myocardial and functional determinants of exercise-induced rise of eNO in HF. METHODS AND
RESULTS: Thirty-four consecutive ambulatory patients with chronic systolic HF (left ventricular ejection fraction [LVEF] ≤45%) underwent symptom-limited cardiopulmonary stress testing and echocardiography. eNO was determined immediately after exercise. Systemic endothelial dysfunction was assessed by asymmetric dimethylarginine (ADMA) and the L-arginine/ADMA ratio. In our study cohort (mean age 53 ± 13 years, 76% male, median LVEF 31%, interquartile range [IQR] 25%-40%), the mean eNO was 23 ± 9 ppb. eNO levels were higher in patients with diastolic dysfunction stages 2 or 3 than stage 1 or normal diastology (26.1 ± 9 vs 19.5 ± 7 ppb; P = .013). eNO had a positive correlation with estimated systolic pulmonary artery pressure (r = 0.57; P = .0009) and indexed left atrium volume (r = 0.43; P = .014), but it did not correlate with cardiopulmonary exercise test parameters, ADMA, or symptom score.
CONCLUSIONS: In contrast to earlier reports, the increase in postexercise eNO observed in stable chronic systolic HF patients may be attributed to the presence of underlying pulmonary venous hypertension probably secondary to advanced diastolic dysfunction.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23040116      PMCID: PMC3466438          DOI: 10.1016/j.cardfail.2012.08.356

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  22 in total

1.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

2.  Repeatability of successive measurements with a portable nitric oxide analyser in patients with suggested or diagnosed asthma.

Authors:  Reijo Takalo; Päivi Piirilä; Anssi R A Sovijärvi
Journal:  Scand J Clin Lab Invest       Date:  2008       Impact factor: 1.713

Review 3.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

4.  Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure.

Authors:  Stuart D Katz; Katarzyna Hryniewicz; Ingrid Hriljac; Kujtim Balidemaj; Clarito Dimayuga; Alhakam Hudaihed; Aleksandr Yasskiy
Journal:  Circulation       Date:  2005-01-17       Impact factor: 29.690

5.  Exhaled nitric oxide and exercise performance in heart failure.

Authors:  P Agostoni; M Bussotti
Journal:  Arch Physiol Biochem       Date:  2003-10       Impact factor: 4.076

Review 6.  Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies.

Authors:  Dimitris Tousoulis; Nikolaos Papageorgiou; Alexandros Briasoulis; Emmanouel Androulakis; Marietta Charakida; Eleftherios Tsiamis; Christodoulos Stefanadis
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

7.  Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy.

Authors:  Reda E Girgis; Hunter C Champion; Gregory B Diette; Roger A Johns; Solbert Permutt; J T Sylvester
Journal:  Am J Respir Crit Care Med       Date:  2005-05-05       Impact factor: 21.405

8.  Exhaled nitric oxide in asthma: progress since the introduction of standardized methodology.

Authors:  Natalia M Grob; Raed A Dweik
Journal:  J Breath Res       Date:  2008-09       Impact factor: 3.262

Review 9.  Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications.

Authors:  G W Rodway; J Choi; L A Hoffman; J M Sethi
Journal:  Chron Respir Dis       Date:  2009       Impact factor: 2.444

10.  Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk.

Authors:  W H Wilson Tang; Zeneng Wang; Leslie Cho; Danielle M Brennan; Stanley L Hazen
Journal:  J Am Coll Cardiol       Date:  2009-06-02       Impact factor: 24.094

View more
  11 in total

Review 1.  Right ventricular afterload and the role of nitric oxide metabolism in left-sided heart failure.

Authors:  Matthias Dupont; W H Wilson Tang
Journal:  J Card Fail       Date:  2013-09-05       Impact factor: 5.712

Review 2.  Novel wireless devices for cardiac monitoring.

Authors:  Joseph A Walsh; Eric J Topol; Steven R Steinhubl
Journal:  Circulation       Date:  2014-08-12       Impact factor: 29.690

3.  Single exhaled breath metabolomic analysis identifies unique breathprint in patients with acute decompensated heart failure.

Authors:  Michael A Samara; W H Wilson Tang; Frank Cikach; Zeynep Gul; Lily Tranchito; Kelly M Paschke; Jamie Viterna; Yuping Wu; Daniel Laskowski; Raed A Dweik
Journal:  J Am Coll Cardiol       Date:  2013-04-02       Impact factor: 24.094

Review 4.  Metabolic Biomarkers in Heart Failure.

Authors:  Chonyang L Albert; W H Wilson Tang
Journal:  Heart Fail Clin       Date:  2018-01       Impact factor: 3.179

Review 5.  Cardiac biomarkers in children with congenital heart disease.

Authors:  Masaya Sugimoto; Seiko Kuwata; Clara Kurishima; Jeong Hye Kim; Yoich Iwamoto; Hideaki Senzaki
Journal:  World J Pediatr       Date:  2015-10-11       Impact factor: 2.764

Review 6.  Exhaled Breath Analysis in Heart Failure.

Authors:  Fabiana G Marcondes-Braga; Guilherme Lopes Batista; Fernando Bacal; Ivano Gutz
Journal:  Curr Heart Fail Rep       Date:  2016-08

Review 7.  Exhaled nitric oxide as a biomarker in COPD and related comorbidities.

Authors:  Mario Malerba; Alessandro Radaeli; Alessia Olivini; Giovanni Damiani; Beatrice Ragnoli; Paolo Montuschi; Fabio L M Ricciardolo
Journal:  Biomed Res Int       Date:  2014-02-27       Impact factor: 3.411

Review 8.  Exercise-Induced Regulation of Redox Status in Cardiovascular Diseases: The Role of Exercise Training and Detraining.

Authors:  Tryfonas Tofas; Dimitrios Draganidis; Chariklia K Deli; Kalliopi Georgakouli; Ioannis G Fatouros; Athanasios Z Jamurtas
Journal:  Antioxidants (Basel)       Date:  2019-12-23

Review 9.  Biomarkers for pediatric pulmonary arterial hypertension - a call to collaborate.

Authors:  Kelley L Colvin; Melanie J Dufva; Ryan P Delaney; D Dunbar Ivy; Kurt R Stenmark; Michael E Yeager
Journal:  Front Pediatr       Date:  2014-02-03       Impact factor: 3.418

10.  Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy.

Authors:  Majid Malekmohammad; Gert Folkerts; Babak Sharif Kashani; Parisa Adimi Naghan; Zahra Habibi Dastenae; Batoul Khoundabi; Johan Garssen; Esmaeil Mortaz; Ian M Adcock
Journal:  BMC Pulm Med       Date:  2019-10-29       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.